Venous Thromboembolism Risk With Contemporary Lenalidomide-Based Regimens Despite Thromboprophylaxis in Multiple Myeloma: A Systematic Review and Meta-Analysis

BACKGROUND: Thromboprophylaxis is routinely used with lenalidomide-based regimens in multiple myeloma because of a substantial risk of venous thromboembolism (VTE). However, little is known about the incidence of VTE with contemporary lenalidomide-based regimens. The objective of the current study w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Chakraborty, Rajshekhar, Riaz, Irbaz Bin, Malik, Saad Ullah, Marneni, Naimisha, Garcia, Alex Mejia, Anwer, Faiz, Khorana, Alok A., Rajkumar, S. Vincent, Kumar, Shaji, Murad, M. Hassan, Wang, Zhen, Khan, Safi U., Majhail, Navneet S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7453956/
https://ncbi.nlm.nih.gov/pubmed/31913498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32682
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky